Clinical Trials Directory

Trials / Unknown

UnknownNCT04945447

Improving Medication Reviews to Polypharmacy Patients

Effects of a Pharmacist Intervention in the Primary Sector on Patients Medication and Health-related Quality of Life: A Randomised Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
400 (estimated)
Sponsor
Aalborg University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Brief summary: The randomised controlled trial investigates the effect of a pharmacist intervention targeting polypharmacy patient at two levels medical clinics and patient level. The purpose is to gain more knowledge to patients and physicians about their medication and to see changes in the patient's medication and health-related quality of life.

Detailed description

The main objective of the randomised controlled trial is to investigate the clinical effects of the roll-out of the systematic offer from Nord-KAP in the North Denmark Region at two different levels (medical clinic and patient-level). The primary outcome is changes in the participant's medicine from baseline to follow up and changes in healthcare usage Secondary outcomes include investigation of cost-effectiveness and changes in patients health-related quality of life. The hypothesis is that the regional intervention delivered by the pharmacists, from Nord-KAP, can lead to a decrease in medical products compared with a control group between baseline and at 6-month follow-up. * Will the use of a pharmacists intervention lead to a decrease in the number of polypharmacy patients in medical clinics compared to a control group of medical clinics? * Will the use of a pharmacist intervention lead to an increase in the polypharmacy patients health-related quality of life compared to a control group?

Conditions

Interventions

TypeNameDescription
OTHERSystematic pharmacist interventionAlready described in the arm group intervention group for patient level

Timeline

Start date
2021-09-01
Primary completion
2024-04-01
Completion
2025-01-01
First posted
2021-06-30
Last updated
2023-02-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04945447. Inclusion in this directory is not an endorsement.